Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus

Background Microvascular disease (MVD) is a potential contributor to the pathogenesis of diabetes mellitus–related cardiac dysfunction. However, there is a paucity of data on the link between MVD and incident heart failure (HF) in type 2 diabetes mellitus. We examined the association of MVD with inc...

Full description

Bibliographic Details
Main Authors: Arnaud D. Kaze, Prasanna Santhanam, Sebhat Erqou, Rexford S. Ahima, Alain Bertoni, Justin B. Echouffo‐Tcheugui
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.018998
_version_ 1819182723018784768
author Arnaud D. Kaze
Prasanna Santhanam
Sebhat Erqou
Rexford S. Ahima
Alain Bertoni
Justin B. Echouffo‐Tcheugui
author_facet Arnaud D. Kaze
Prasanna Santhanam
Sebhat Erqou
Rexford S. Ahima
Alain Bertoni
Justin B. Echouffo‐Tcheugui
author_sort Arnaud D. Kaze
collection DOAJ
description Background Microvascular disease (MVD) is a potential contributor to the pathogenesis of diabetes mellitus–related cardiac dysfunction. However, there is a paucity of data on the link between MVD and incident heart failure (HF) in type 2 diabetes mellitus. We examined the association of MVD with incident HF in adults with type 2 diabetes mellitus. Methods and Results A total of 4095 participants with type 2 diabetes mellitus and free of HF were assessed for diabetes mellitus–related MVD including nephropathy, retinopathy, or neuropathy at baseline in the Look AHEAD (Action for Health in Diabetes) study. Incident HF events were prospectively assessed and adjudicated using hospital and death records. Cox models were used to generate hazard ratios and 95% CIs for HF. Of 4095 participants, 34.8% (n=1424) had MVD, defined as the presence of ≥1 of nephropathy, retinopathy, or neuropathy at baseline. Over a median of 9.7 years, there were 117 HF events. After adjusting for relevant confounders, participants with MVD had a 2.5‐fold higher risk of incident HF than those without MVD (hazard ratio, 2.54; 95% CI, 1.73–3.75). This association remained significant after additional adjustment for interval development of coronary artery disease (hazard ratio, 2.42; 95% CI, 1.64–3.57). The hazard ratios for HF by type of MVD were 2.22 (95% CI, 1.51–3.27), 1.30 (95% CI, 0.72–2.36), and 1.33 (95% CI, 0.86–2.07) for nephropathy, retinopathy, and neuropathy, respectively. CONCLUSIONS MVD is associated with an excess HF risk in individuals with type 2 diabetes mellitus after adjusting for other known risk factors. Our findings underscore the contribution of MVD to the development of diabetes mellitus–related HF. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00017953.
first_indexed 2024-12-22T22:50:39Z
format Article
id doaj.art-a54c3d80d91a486087c87ba5ee279549
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-22T22:50:39Z
publishDate 2021-06-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-a54c3d80d91a486087c87ba5ee2795492022-12-21T18:09:58ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802021-06-01101210.1161/JAHA.120.018998Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes MellitusArnaud D. Kaze0Prasanna Santhanam1Sebhat Erqou2Rexford S. Ahima3Alain Bertoni4Justin B. Echouffo‐Tcheugui5Department of Medicine University of Maryland Medical Center Baltimore MDDivision of Endocrinology, Diabetes & Metabolism Johns Hopkins School of Medicine Baltimore MDDepartment of Medicine Providence VA Medical Center and Alpert Medical School of Brown University Providence RIDivision of Endocrinology, Diabetes & Metabolism Johns Hopkins School of Medicine Baltimore MDDepartment of Epidemiology and Prevention Wake Forest University School of Medicine Winston‐Salem NCDivision of Endocrinology, Diabetes & Metabolism Johns Hopkins School of Medicine Baltimore MDBackground Microvascular disease (MVD) is a potential contributor to the pathogenesis of diabetes mellitus–related cardiac dysfunction. However, there is a paucity of data on the link between MVD and incident heart failure (HF) in type 2 diabetes mellitus. We examined the association of MVD with incident HF in adults with type 2 diabetes mellitus. Methods and Results A total of 4095 participants with type 2 diabetes mellitus and free of HF were assessed for diabetes mellitus–related MVD including nephropathy, retinopathy, or neuropathy at baseline in the Look AHEAD (Action for Health in Diabetes) study. Incident HF events were prospectively assessed and adjudicated using hospital and death records. Cox models were used to generate hazard ratios and 95% CIs for HF. Of 4095 participants, 34.8% (n=1424) had MVD, defined as the presence of ≥1 of nephropathy, retinopathy, or neuropathy at baseline. Over a median of 9.7 years, there were 117 HF events. After adjusting for relevant confounders, participants with MVD had a 2.5‐fold higher risk of incident HF than those without MVD (hazard ratio, 2.54; 95% CI, 1.73–3.75). This association remained significant after additional adjustment for interval development of coronary artery disease (hazard ratio, 2.42; 95% CI, 1.64–3.57). The hazard ratios for HF by type of MVD were 2.22 (95% CI, 1.51–3.27), 1.30 (95% CI, 0.72–2.36), and 1.33 (95% CI, 0.86–2.07) for nephropathy, retinopathy, and neuropathy, respectively. CONCLUSIONS MVD is associated with an excess HF risk in individuals with type 2 diabetes mellitus after adjusting for other known risk factors. Our findings underscore the contribution of MVD to the development of diabetes mellitus–related HF. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00017953.https://www.ahajournals.org/doi/10.1161/JAHA.120.018998heart failuremicrovascular diseasetype 2 diabetes mellitus
spellingShingle Arnaud D. Kaze
Prasanna Santhanam
Sebhat Erqou
Rexford S. Ahima
Alain Bertoni
Justin B. Echouffo‐Tcheugui
Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
heart failure
microvascular disease
type 2 diabetes mellitus
title Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus
title_full Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus
title_fullStr Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus
title_full_unstemmed Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus
title_short Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus
title_sort microvascular disease and incident heart failure among individuals with type 2 diabetes mellitus
topic heart failure
microvascular disease
type 2 diabetes mellitus
url https://www.ahajournals.org/doi/10.1161/JAHA.120.018998
work_keys_str_mv AT arnauddkaze microvasculardiseaseandincidentheartfailureamongindividualswithtype2diabetesmellitus
AT prasannasanthanam microvasculardiseaseandincidentheartfailureamongindividualswithtype2diabetesmellitus
AT sebhaterqou microvasculardiseaseandincidentheartfailureamongindividualswithtype2diabetesmellitus
AT rexfordsahima microvasculardiseaseandincidentheartfailureamongindividualswithtype2diabetesmellitus
AT alainbertoni microvasculardiseaseandincidentheartfailureamongindividualswithtype2diabetesmellitus
AT justinbechouffotcheugui microvasculardiseaseandincidentheartfailureamongindividualswithtype2diabetesmellitus